Clinical outcomes in real-world patients with acute myocardial infarction receiving XIENCE V® everolimus-eluting stents: one-year results from the XIENCE V USA study. [electronic resource]
Producer: 20140604Description: E385-94 p. digitalISSN:- 1522-726X
- Aged
- Cardiovascular Agents -- administration & dosage
- Coronary Thrombosis -- etiology
- Drug-Eluting Stents
- Everolimus
- Female
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- diagnosis
- Percutaneous Coronary Intervention -- adverse effects
- Product Surveillance, Postmarketing
- Prospective Studies
- Risk Factors
- Sirolimus -- administration & dosage
- Time Factors
- Treatment Outcome
- United States
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.